Search

everythinglearnresearchcommunity

for

Search:↓

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Fullerenes show potential in skin care but need more safety research.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Adrenal disorders can cause lasting brain and behavior issues in children.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

COVID-19 may harm male fertility and damage the reproductive system.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The Chinese version of the PCOS quality of life questionnaire is reliable and valid for Chinese-speaking women with PCOS.